Former Chief Executive Officer, Former Executive Chairman of the Board · Coya Therapeutics, Inc. (COYA)

Howard Berman

A named executive officer of Coya Therapeutics in every fiscal year CompBrief holds from FY2021 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$1,471,701

Salary $436,800Stock awards $0Bonus $316,680

FY2024: $2,680,268

2nd of 4 named executive officers at Coya Therapeutics by FY2025 total.

4 named officers on file for Coya Therapeutics, FY2025

Howard Berman’s pay file — $29

  • 5 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Coya Therapeutics’s whole pay program stands against its peers

  • Coya Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on COYA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed May 13, 2026 (DEF 14A).

Free

Get Howard Berman’s full pay file as a PDF — free

More than this page: up to 10 years of Howard’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Howard Berman compensation by year

Coya Therapeutics Summary Compensation Table · all 5 fiscal years held
In US dollars, as Coya Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2022FY2023FY2024FY2025
Salary$300,000$412,500$580,000$553,333$436,800
Bonus$90,000$185,625$253,750$276,667$316,680
Stock awards$0$0$0$0$0
Option awards$0$0$483,450$1,850,268$718,221
Non-equity incentive$0$0$0$0$0
Pension and deferred compensation$0$0$0$0$0
All other$0$0$0$0$0
Total$390,000$598,125$1,317,200$2,680,268$1,471,701

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Coya Therapeutics, Inc. DEF 14A filed May 13, 2026, accession 0001193125-26-220688, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Coya Therapeutics, Inc. filed document, accession 0001193125-26-220688. Every figure is read from that document and cited to the page and table it appears in. Filed May 13, 2026.

$390K
$598K
$1.3M
$2.7M
$1.5M
FY21
FY22
FY23
FY24
FY25
SalaryBonusOption awards

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
Option9,167—$3.85
Option55,857—$5.90
Option77,286—$8.15
Option104,585—$6.07

Per the Outstanding Equity Awards at Fiscal Year-End table in Coya Therapeutics, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Coya Therapeutics’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Arun SwaminathanChief Executive Officer, Director$2,091,007
Howard Berman · this pageFormer Chief Executive Officer, Former Executive Chairman of the Board$1,471,701
Fred GrossmanPresident, Chief Medical Officer$1,457,433
David SnyderChief Financial Officer and Chief Operating Officer$1,368,700

The full Coya Therapeutics compensation record

free company brief

This page is one person within Coya Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Coya Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Howard Berman's compensation dossier · One-time report. No refunds.